Wednesday, July 8, 2026

Drug profile · INN

probenecid

probenecid (PRO-CID) is a solute carrier family 22 member 6 inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

FDA: approved TGA: approved
US status approved
Patents linked 3
Pipeline programs 4
News articles 0
Drug details — probenecid
US status
approved
Class
Route
ORAL
Patents
3
Programs
4
Data quality
0.89

Quick answer

probenecid (PRO-CID) is a solute carrier family 22 member 6 inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN probenecid
Brand PRO-CID
Mechanism Solute carrier family 22 member 6 inhibitor
Target Solute carrier family 22 member 11
Route ORAL
Formulation TABLET

Mechanism of action

Solute carrier family 22 member 6 inhibitor

Primary target: Solute carrier family 22 member 11

Approval history

Authority Status Date
FDA approved
TGA approved

Pipeline programs

  1. Sulopenem etzadroxil/probenecid Phase 3 · Iterum Therapeutics · Urinary Tract Infections
  2. Sulopenem-Etzadroxil/Probenecid Phase 3 · Iterum Therapeutics · Uncomplicated Urinary Tract Infections
  3. 1378-0025 Phase 1 · Boehringer Ingelheim · Healthy volunteer trial
  4. sulopenem etzadroxil and probenecid Phase 1 · Iterum Therapeutics · Pharmacokinetics After Oral Intake
  1. US 12128034

    Combinations of beta-lactam compounds, probenecid, and valproic acid and uses thereof

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 12109197

    Combinations of β-lactam compounds and probenecid and uses thereof

    Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 11478428

    Combinations of beta-lactam compounds and probenecid and uses thereof

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is probenecid?

probenecid (PRO-CID) is a solute carrier family 22 member 6 inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for probenecid?

PRO-CID is a marketed brand name for probenecid. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of probenecid?

probenecid has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.